Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011

详细信息    查看全文

• 作者：Junichi Kurebayashi ; Yasuo Miyoshi ; Takashi Ishikawa ; Shigehira Saji…
• 关键词：Clinicopathological characteristics ; Trends in the management of breast cancer patients ; Japanese Breast Cancer Society ; Registry ; Japan
• 刊名：Breast Cancer
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：22
• 期：3
• 页码：235-244
• 全文大小：642 KB
• 参考文献：1.Center for Cancer Control and Information Services, National Cancer Center, Japan. http://?ganjoho.?jp/?public/?index.?html .
  2.Tokuda Y. The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives. Nihon Geka Gakkai Zasshi. 2014;115(1):17-1 (in Japanese).PubMed
  3.Greene FL. Breast tumours. In: Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002. p. 131-1.
  4.World Health Organization. Tumours of the Breast and Female Genital Organs. Oxford: Oxford University Press; 2003.
  5.Pant K, Dutta U. Understanding and management of male breast cancer: a critical review. Med Oncol. 2008;25(3):294-.View Article PubMed
  6.Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol. 2007;25(27):4210-.View Article PubMed
  7.Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88(12):2739-0.View Article PubMed
  8.Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah population database. JAMA. 1993;270(13):1563-.View Article PubMed
  9.Surveillance, Epidemiology, End Results Program. http://?seer.?cancer.?gov/?statfacts/?html/?breast.?html .
  10.Kim Z, Min SY, Yoon CS, Lee HJ, Lee JS, Youn H, et al. Korean Breast Cancer Society. The basic facts of Korean breast cancer in 2011: results of a nationwide survey and breast cancer registry database. J Breast Cancer. 2014;17(2):99-06.View Article PubMed Central PubMed
  11.Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, ATAC Trialists-Group, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359(9324):2131-.View Article PubMed
  12.Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol. 2013;24(10):2506-4.View Article PubMed Central PubMed
  13.Ministry of Health, Labour and Welfare, Japan. http://?www.?mhlw.?go.?jp/?toukei/?saikin/?hw/?k-tyosa/?k-tyosa13/?index.?html .
  14.Chen AC, Paulino AC, Schwartz MR, Rodriguez AA, Bass BL, Chang JC, Teh BS. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014;111(3):619-2.View Article PubMed
  15.Brouckaert OI, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F, et al. Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Ann Oncol. 2012;23(10):2578-4.View Article PubMed
  16.Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350:1430-1.View Article PubMed
  17.Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289(11):1421-.View Article PubMed
  18.Ellis IO, Cornelisse CJ, Schnitt SJ, Sasco AJ, Sastre-Garau X, Kaaks R, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumors: pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 13-9.
  19.Yamashita H, Iwase H, Toyama T, Takahashi S, Sugiura H, et al. Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol. 2011;22:1318-5.View Article PubMed
  20.Hosoda M, Yamamoto M, Nakano K, Hatanaka K, Takakuwa E, Hatanaka Y, et al. Differential expression of progesterone receptor, FOXA1, GATA3 and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2014;144:249-1.View Article PubMed
  21.Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst. 2012;104(14):1094-01.View Article PubMed Central PubMed
  22.Ko BS, Noh WC, Kang SS, Park BW, Kang EY, Paik NS, et al. Korean Breast Cancer Society. Changing patterns in the clinical characteristics of Korean breast cancer from 1996-2010 using an online nationwide breast cancer database. J Breast Cancer. 2012;15:393-00.View Article PubMed Central PubMed
  23.Leong SPL, Shen Z-Z, Liu T-J, Agarwal G, Tajima T, Paik N-S, Sandelin K, et al. Is breast cancer the same disease in Asian and Western Countries? World J Surg. 2010;34:2308-4.View Article PubMed Central PubMed
  24.Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgi
• 作者单位：Junichi Kurebayashi (1) (2)
  Yasuo Miyoshi (3)
  Takashi Ishikawa (4)
  Shigehira Saji (5)
  Tomoharu Sugie (6)
  Takashi Suzuki (7)
  Shunji Takahashi (8)
  Miwako Nozaki (9)
  Hiroko Yamashita (10)
  Yutaka Tokuda (11) (12)
  Seigo Nakamura (13) (14)
  
  1. Department of Breast and Thyroid Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan
  2. Committee of Academic Affairs, The Japanese Breast Cancer Society, Tokyo, Japan
  3. Division of Breast and Endocrine, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan
  4. Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan
  5. Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan
  6. Department of Surgery, Kansai Medical University, Hirakata, Japan
  7. Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan
  8. Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
  9. Department of Radiology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan
  10. Department of Breast Surgery, Hokkaido University Hospital, Sapporo, Japan
  11. Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan
  12. Committee of Breast Cancer Registration, The Japanese Breast Cancer Society, Tokyo, Japan
  13. Division of Breast Surgical Oncology, Department of Surgery, Showa University, Tokyo, Japan
  14. Board of Directors, The Japanese Breast Cancer Society, Tokyo, Japan
  
• 刊物主题：Surgical Oncology; Oncology; Surgery; Cancer Research;
• 出版者：Springer Japan
• ISSN：1880-4233

文摘

Purposes We conducted a study to analyze the clinicopathological characteristics of breast cancer in Japan registered to the Japanese Breast Cancer Registry of the Japanese Breast Cancer Society (JBCS). Trends in the management of breast cancer patients in Japan were also analyzed. Patients and methods More than 250,000 breast cancer patients were registered to the JBCS registry between 2004 and 2011. Demographic and clinicopathological factors in newly diagnosed primary breast cancer patients were registered to the JBCS through the Web-based system from affiliated institutes nationwide. Results Two distinct peaks were observed, in patients in their late 40s and early 60s, in the population-adjusted age distribution of breast cancer patients. An increased rate of screen-detected breast cancer may contribute to an earlier detection of breast cancer and increased rate of non-invasive ductal carcinoma. The positive rate of either ER or PgR appears to have increased in recent years. The annual rates of patients treated with breast-conserving surgery increased until 2006, but these increases stopped in 2007 and thereafter plateaued at approximately 60?%. The annual rates of patients treated with sentinel lymph node dissection alone have steadily increased. The annual rates of patients treated with preoperative trastuzumab plus chemotherapy have also increased, as well as those treated with postoperative aromatase inhibitors. The annual rates of patients treated with postoperative anthracycline-containing regimens have decreased, whereas those treated with postoperative taxane-containing regimens have increased. The postoperative use of trastuzumab has markedly increased since 2007. Conclusion Although this study was based on the registry database, several unique clinicopathological characteristics of breast cancer in Japan have been unveiled. Our results suggest that recent trends in the management of breast cancer patients in Japan were strongly followed by clinical evidence that originated from a number of clinical trials worldwide.